These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34503519)

  • 1. Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
    Taylor WR; Hoglund RM; Peerawaranun P; Nguyen TN; Hien TT; Tarantola A; von Seidlein L; Tripura R; Peto TJ; Dondorp AM; Landier J; H Nosten F; Smithuis F; Phommasone K; Mayxay M; Kheang ST; Say C; Neeraj K; Rithea L; Dysoley L; Kheng S; Muth S; Roca-Feltrer A; Debackere M; Fairhurst RM; Song N; Buchy P; Menard D; White NJ; Tarning J; Mukaka M
    Malar J; 2021 Sep; 20(1):366. PubMed ID: 34503519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
    Milligan R; Daher A; Graves PM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.
    Shimizu S; Kikuchi T; Koga M; Kato Y; Matsuoka H; Maruyama H; Kimura M;
    Travel Med Infect Dis; 2015; 13(3):235-40. PubMed ID: 25482427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN
    Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doses of primaquine administered to children with
    Vieira MVDF; Matos Lopes TR; Mello AGNC; de Sena LWP; Commons RJ; Vieira JLF
    Pathog Glob Health; 2020 Oct; 114(7):388-392. PubMed ID: 32705964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of relapsing Plasmodium vivax malaria.
    Chu CS; White NJ
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
    Malla P; Wang Z; Brashear A; Yang Z; Lo E; Baird K; Wang C; Cui L
    J Infect Dis; 2024 May; 229(5):1557-1564. PubMed ID: 38041857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of anti-malarial drugs against clinical Plasmodium vivax malaria in Ethiopia: a systematic review and meta-analysis.
    Ketema T; Bacha K; Getahun K; Bassat Q
    Malar J; 2021 Dec; 20(1):483. PubMed ID: 34952581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.
    Taylor WR; Naw HK; Maitland K; Williams TN; Kapulu M; D'Alessandro U; Berkley JA; Bejon P; Okebe J; Achan J; Amambua AN; Affara M; Nwakanma D; van Geertruyden JP; Mavoko M; Lutumba P; Matangila J; Brasseur P; Piola P; Randremanana R; Lasry E; Fanello C; Onyamboko M; Schramm B; Yah Z; Jones J; Fairhurst RM; Diakite M; Malenga G; Molyneux M; Rwagacondo C; Obonyo C; Gadisa E; Aseffa A; Loolpapit M; Henry MC; Dorsey G; John C; Sirima SB; Barnes KI; Kremsner P; Day NP; White NJ; Mukaka M
    BMC Med; 2018 Jan; 16(1):11. PubMed ID: 29347975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
    Nekkab N; Lana R; Lacerda M; Obadia T; Siqueira A; Monteiro W; Villela D; Mueller I; White M
    PLoS Med; 2021 Apr; 18(4):e1003535. PubMed ID: 33891582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher-Dose Primaquine to Prevent Relapse of
    Chamma-Siqueira NN; Negreiros SC; Ballard SB; Farias S; Silva SP; Chenet SM; Santos EJM; Pereira de Sena LW; Póvoa da Costa F; Cardoso-Mello AGN; Marchesini PB; Peterka CRL; Viana GMR; Macedo de Oliveira A
    N Engl J Med; 2022 Mar; 386(13):1244-1253. PubMed ID: 35353962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium vivax malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil.
    Pedro RS; Guaraldo L; Campos DP; Costa AP; Daniel-Ribeiro CT; Brasil P
    Malar J; 2012 Jul; 11():245. PubMed ID: 22839416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
    Krudsood S; Tangpukdee N; Wilairatana P; Phophak N; Baird JK; Brittenham GM; Looareesuwan S
    Am J Trop Med Hyg; 2008 May; 78(5):736-40. PubMed ID: 18458306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin.
    de Sena LWP; Mello AGNC; Ferreira MVD; de Ataide MA; Dias RM; Vieira JLF
    Malar J; 2019 Dec; 18(1):439. PubMed ID: 31864358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
    Kristensen KL; Dragsted UB
    Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison.
    Valdes A; Epelboin L; Mosnier E; Walter G; Vesin G; Abboud P; Melzani A; Blanchet D; Blaise N; Nacher M; Demar M; Djossou F
    Malar J; 2018 Jun; 17(1):237. PubMed ID: 29921273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
    Pukrittayakamee S; Imwong M; Chotivanich K; Singhasivanon P; Day NP; White NJ
    Am J Trop Med Hyg; 2010 Apr; 82(4):542-7. PubMed ID: 20348496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.
    Leang R; Khu NH; Mukaka M; Debackere M; Tripura R; Kheang ST; Chy S; Kak N; Buchy P; Tarantola A; Menard D; Roca-Felterer A; Fairhurst RM; Kheng S; Muth S; Ngak S; Dondorp AM; White NJ; Taylor WR
    BMC Med; 2016 Oct; 14(1):171. PubMed ID: 27784313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.